Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Ropinirole XR in RLS
NCT00355641Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ropinirole in restless legs syndrome (RLS), sponsored by GSK. Started Oct 2005; status: completed.
02
Drugs
ropinirole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00355641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00355641.